IMS reaffirms positive growth outlook for 2008 and produces a surge its stock price. Expected growth for FY2008 is expected to be at around 6%-9%.
IMS Health announced a fall of 18 percent in Q3 profit, as the company was affected by changes in German tax rate. The company reported a net profit of $57.1 million, compared with a profit of $69.3 million last year. The revenue for the quarter was $538.8 million, which was an increase of 12 percent from last year. The increase in the revenue was mainly due to gain in U.S. operations and growth in Europe.